Taruc, Marites M.

HRN: 04-08-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2023
CEFTAZIDIME 1GM (VIAL)
12/13/2023
12/19/2023
IV
1g
Q8
T/C Meningitis
Waiting Final Action 
12/16/2023
CEFTRIAXONE 1G (VIAL)
12/16/2023
12/23/2023
IV
2g
OD
Meningitis
Waiting Final Action 
12/18/2023
CEFTRIAXONE 1G (VIAL)
12/18/2023
12/24/2023
IV
2g
Q12
Meningitis
Waiting Final Action 
12/22/2023
CEFTRIAXONE 1G (VIAL)
12/23/2023
12/26/2023
IV
2g
IV
T/cC Meningitis
Waiting Final Action 
12/22/2023
LEVOFLOXACIN 500MG (TAB)
12/22/2023
12/26/2023
NGT
500mg/tab
OD
T/C Meningitis
Waiting Final Action 
12/23/2023
CEFTRIAXONE 1G (VIAL)
12/23/2023
12/25/2023
IV
2gm
Q12
T/C Meningitis
Waiting Final Action 
12/23/2023
LEVOFLOXACIN 500MG (TAB)
12/23/2023
12/27/2023
PO
750mg
OD
T/C Meningitis
Waiting Final Action 
12/23/2023
CEFTAZIDIME 1GM (VIAL)
12/23/2023
01/16/2024
IV
2g
Q8
Meningitis/ Pneumonia
Waiting Final Action 
01/03/2024
MUPIROCIN 2%, 15G (TUBE)
01/03/2024
01/09/2024
TOPICAL
2%
Q12
Decubitus Ulcer Sacral Area
Waiting Final Action 
01/06/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/06/2024
01/12/2024
IVT
4.5g
Q8
T/c Meningitis; Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: